Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$593M |
| 2 |
Abbott
ABT
|
+$259M |
| 3 |
AutoZone
AZO
|
+$204M |
| 4 |
AABA
Altaba Inc
AABA
|
+$186M |
| 5 |
D.R. Horton
DHI
|
+$178M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$215M |
| 2 |
Public Service Enterprise Group
PEG
|
+$211M |
| 3 |
Applied Materials
AMAT
|
+$203M |
| 4 |
Intuitive Surgical
ISRG
|
+$194M |
| 5 |
ConocoPhillips
COP
|
+$192M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.49% |
| 2 | Technology | 12.13% |
| 3 | Healthcare | 11.89% |
| 4 | Consumer Discretionary | 11.58% |
| 5 | Industrials | 10.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MDRX
826
DELISTED
Veradigm Inc. Common Stock
MDRX
| $22.7M | 0.03% |
1,558,778
-3,421,895
| -69% | -$47.5M |
|
827
Tenet Healthcare
THC
$22.4B
| $22.7M | 0.03% |
+1,494,412
| New | +$21M |
|
828
Matthews International
MATW
$662M
| $22.6M | 0.03% |
428,250
+315,954
| +281% | +$18.4M |
|
829
Cullen/Frost Bankers
CFR
$10.2B
| $22.6M | 0.03% |
238,653
+98,254
| +70% | +$9.46M |
|
830
Graco
GGG
$13B
| $22.6M | 0.03% |
499,485
+100,074
| +25% | +$4.33M |
|
831
Itron
ITRI
$4.32B
| $22.5M | 0.03% |
329,596
+168,961
| +105% | +$12.1M |
|
832
iShares Core S&P 500 ETF
IVV
$891B
| $22.5M | 0.03% |
83,553
+56,615
| +210% | +$14.8M |
|
833
Nutanix
NTNX
$18B
| $22.4M | 0.03% |
636,257
-514,391
| -45% | -$15.6M |
|
834
Herc Holdings
HRI
$5.28B
| $22.4M | 0.03% |
+358,282
| New | +$19.7M |
|
|
VNTR
835
DELISTED
Venator Materials PLC
VNTR
| $22.4M | 0.03% |
1,013,731
-453,541
| -31% | -$10.4M |
|
836
Edgewell Personal Care
EPC
$1.31B
| $22.4M | 0.03% |
377,339
-180,689
| -32% | -$11.4M |
|
|
AERI
837
DELISTED
Aerie Pharmaceuticals
AERI
| $22.4M | 0.03% |
374,655
+109,857
| +41% | +$6.66M |
|
838
Braskem
BAK
$733M
| $22.4M | 0.03% |
851,567
+84,092
| +11% | +$2.4M |
|
|
CTLT
839
DELISTED
CATALENT, INC.
CTLT
| $22.3M | 0.03% |
543,070
-1,438,903
| -73% | -$58.6M |
|
|
ADMS
840
DELISTED
Adamas Pharmaceuticals
ADMS
| $22.3M | 0.03% |
657,083
-603,496
| -48% | -$16.9M |
|
|
CTRA
841
DELISTED
Coterra Energy
CTRA
| $22.2M | 0.03% |
777,228
-955,307
| -55% | -$26.2M |
|
842
Group 1 Automotive
GPI
$3.09B
| $22.2M | 0.03% |
312,699
+191,709
| +158% | +$14.6M |
|
|
MB
843
DELISTED
MINDBODY, Inc. Class A Common Stock
MB
| $22.2M | 0.03% |
728,570
+346,862
| +91% | +$10.7M |
|
|
UNVR
844
DELISTED
Univar Solutions Inc.
UNVR
| $22.1M | 0.03% |
715,033
+57,680
| +9% | +$1.72M |
|
845
Ingevity
NGVT
$2.37B
| $22.1M | 0.03% |
313,101
-114,804
| -27% | -$8.28M |
|
846
Wintrust Financial
WTFC
$10.3B
| $21.9M | 0.03% |
266,300
-75,882
| -22% | -$6.11M |
|
|
ZGNX
847
DELISTED
Zogenix, Inc.
ZGNX
| $21.9M | 0.03% |
545,753
-577,199
| -51% | -$22.2M |
|
|
ORBK
848
DELISTED
Orbotech Ltd
ORBK
| $21.8M | 0.03% |
432,955
+189,921
| +78% | +$9.25M |
|
849
Kroger
KR
$36.2B
| $21.7M | 0.03% |
791,832
-5,261,259
| -87% | -$123M |
|
850
SLM Corp
SLM
$4.95B
| $21.7M | 0.03% |
1,923,202
-305,918
| -14% | -$3.35M |
|
Similar funds
Israel Englander's Q4 2017 Portfolio in Review
As of Q4 2017, Israel Englander held 4,357 positions worth $72.5B, up 10% from $65.6B the previous quarter. Its ten largest holdings account for 6.7% of the portfolio.
Israel Englander deployed $3.05B of net new capital in Q4 2017, opening 897 new positions and adding to 1,473 existing holdings. Its largest new stake was Viatris: 2,905,317 shares worth $123M.
By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 14% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Honeywell, an estimated $215M trimmed.
- Israel Englander's largest Q4 2017 buy was Viatris: 2,905,317 shares worth $123M.
- Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $593M increase.
- Israel Englander's biggest Q4 2017 reduction was Honeywell, cutting an estimated $215M.
- Israel Englander fully exited Paychex in Q4 2017, selling an estimated $66.4M.
- Israel Englander's ten largest holdings make up 6.7% of its $72.5B portfolio in Q4 2017.
- Israel Englander opened 897 new positions and closed 601 in Q4 2017.
- Israel Englander's portfolio value rose 10% quarter-over-quarter to $72.5B.
Based on Millennium Management's 13F filing for Q4 2017, filed 14 Feb 2018.